Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343
about
Management of early breast cancer in older women: from screening to treatmentThe Right Treatment for the Right Patient – Personalised Treatment of Breast CancerScreening mammography in older women: a reviewLandmark trials affecting the surgical management of invasive breast cancerReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceIntraoperative radiotherapy for breast cancer: the lasting effects of a fleeting treatmentOptimal management of breast cancer in the elderly patient: current perspectivesAdjuvant treatment for older women with invasive breast cancerIs IORT ready for roll-out?Intraoperative radiation therapy for breast cancer patients: current perspectivesSurveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.For-profit hospital ownership status and use of brachytherapy after breast-conserving surgeryEffect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinoma in situ: a meta-analysis.Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy.Older women's experience with breast cancer treatment decisionsAdvances in managing breast cancer: a clinical updateAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2014.Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT.Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGITEffects of age on the detection and management of breast cancer.TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.Meeting highlights: the first korean breast cancer treatment consensus conference.Individual, Area, and Provider Characteristics Associated With Care Received for Stages I to III Breast Cancer in a Multistate Region of Appalachia.Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centreAddressing overdiagnosis and overtreatment in cancer: a prescription for changeThe treatment of early breast cancer in women over the age of 70How can we best respect patient autonomy in breast cancer treatment decisions?Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer.The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.The real difficulty in improving concordance of clinical practice with guidelinesEarly breast cancer in the older woman.Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up.Different methods for target volume delineation of glandular breast tissue following breast-conserving surgery in breast cancer: A comparative study.A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.Assessing the impact of a cooperative group trial on breast cancer care in the medicare population.Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survivalSEOM clinical guidelines in early-stage breast cancer 2015Sorting out the survival impact of radiation therapy in early-stage invasive breast cancer.
P2860
Q26799695-7B654B22-F298-46BE-8CCA-24125F01DE14Q26800260-E0414729-ED62-4C07-9AEE-785EAA3DC9B9Q26829839-5A260D83-16B7-4A56-9960-7102B2284399Q26830129-FF436C80-DE34-46BB-AEBE-210D5BDBAAD9Q27009163-F4223D08-13C0-4907-8440-C28A90BDB2C9Q27014710-5257E85A-7B8F-48D4-87EC-F0DD7C788925Q27690879-7D8AF638-E3C0-4882-AE2E-357B3F71B695Q28066744-2C226935-AC13-4703-BBCF-07744811A7AEQ28082735-53EB697B-1770-49AA-BB0B-D6DF5E91FF7FQ30252472-6AA0E35D-0FBD-4666-A51C-2CE8FD49A4B4Q30395721-FEAA29AA-A36C-4218-9033-4C12310B7956Q30768230-69598993-6144-488E-B3BA-90169A60F19EQ30992150-29B433DA-0AE0-4746-A5CC-0F7CC82654DDQ33561585-FEEAB2B6-2057-437C-B454-C3E3BB549209Q33709640-E7CCBF99-5C16-4C69-A0D8-1960BFA6885AQ33711787-FFB6D6FC-11A2-4745-9D7A-3CFE953EA695Q33980622-734EFF10-E31F-476B-A441-F1D06BF8B8DAQ34019904-6FA3C675-BC1C-4C5F-953E-8C4BDFCE1099Q34042627-BD23ECEC-F0E8-442D-A639-2240EC4C81C5Q34303451-06046865-317B-4D21-A380-A1433F332CD8Q34303459-8A77BD00-4748-4465-AAEA-C162ADF59D40Q34477879-8F675C5A-ACBD-41D2-B1CA-59DC99BEB1CEQ34525801-CAA25BD3-3113-4844-9A78-FC54CB2B7FA7Q34779593-2F37D9CC-B08D-455B-A684-C68FD28009CAQ34968981-BD18937B-F6DE-4646-970A-2B1EE03EDA97Q35006855-0FDBDD14-DA0F-4A37-A365-0CC4B822866EQ35067706-F8FCE730-6800-4A0C-8B48-B83231AA730EQ35125666-B056857C-ECE8-4238-B82A-61158561BD44Q35127923-DF523DF2-DC22-49C6-8883-D3E113584F9EQ35237212-095A4CDB-062B-4807-8A17-CD545BEF2D46Q35475576-814B47F8-5E71-4E5A-83A4-55E19A9633CEQ35561331-9E33FF6A-014D-48B3-82F0-502C8B8B927BQ35584539-7F97CA15-56D4-44BB-BBE9-AA7DF374E078Q35797762-1F7BABBE-A0AE-41D5-9C0C-B5364E4EB63CQ35871477-A85A0211-A28A-45A9-9462-A7DF42F8A753Q35884665-8DE328C3-B6AD-4131-9E15-3E1B74FDD258Q36058251-2BDE49C0-D445-4304-A40D-E28C8B75AA69Q36193393-43F9BDF9-724D-47B7-A8DF-799D60BBB0C9Q36400320-9F754C2D-61BD-4152-9CB1-0413CF02D6A0Q36438752-1545407D-4A15-450C-B135-F2A1801133AD
P2860
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lumpectomy plus tamoxifen with ...... g-term follow-up of CALGB 9343
@en
type
label
Lumpectomy plus tamoxifen with ...... g-term follow-up of CALGB 9343
@en
prefLabel
Lumpectomy plus tamoxifen with ...... g-term follow-up of CALGB 9343
@en
P2093
P2860
P356
P1476
Lumpectomy plus tamoxifen with ...... g-term follow-up of CALGB 9343
@en
P2093
Barbara L Smith
Clifford A Hudis
Constance T Cirrincione
Donald A Berry
Eric P Winer
Hyman B Muss
Jennifer R Bellon
Lauren A Schnaper
William C Wood
P2860
P304
P356
10.1200/JCO.2012.45.2615
P407
P577
2013-05-20T00:00:00Z